Megaloblastic anemia is one form of macrocytic anemia in which red blood cells become enlarged and oval-shaped. It is caused by deficiencies of vitamin B12 (cobalamin) or folate, and numerous hematologic and neurologic abnormalities can result from the impaired DNA processes these deficiencies can cause.
Vitamin B12 deficiency causes subacute combined neurologic degeneration, which can be severe and sometimes irreversible. Neurologic defects may occur with or without anemia. The signs and symptoms include:
- Paresthesias of the hands and feet, loss of proprioception, and loss of vibratory sense.
- Symmetrical and progressive spastic and ataxic weakness.
- Loss of deep tendon reflexes.
- Irritability and mental status changes (megaloblastic madness).
- Memory disturbances.
Other symptoms of vitamin B12 or folate deficiency may include fatigue, weakness, glossitis, gastrointestinal problems (e.g., diarrhea), decreased appetite, changes in taste, and weight loss. These symptoms sometimes precede anemia. However, megaloblastic anemia is often asymptomatic until the condition is quite severe.
Vitamin B12 deficiency may result from:
Age. Ten to 30 percent of older people may be unable to absorb naturally occurring vitamin B12.
Intrinsic factor deficiency. Intrinsic factor is required for vitamin B12 absorption. A deficiency can occur congenitally or through chronic gastritis, gastrectomy, or autoimmune processes directed at intrinsic factor or the gastric parietal cells that produce it. When anemia results from an intrinsic factor deficiency, it is called pernicious anemia.
Malabsorption. Pancreatic disease, small bowel disease (especially Crohn’s disease), and alcohol abuse contribute to poor B12 absorption.
Other gastric disease. Occasionally, individuals with H. pylori gastritis, total or partial gastrectomy, or gastric bypass may develop a B12 deficiency.
Medications. Metformin (reversible with calcium supplements), proton pump inhibitors, H2 blockers, antacids, and antibiotic use (with subsequent bacterial overgrowth) may inhibit B12 absorption.
HIV infection. Weight loss and diarrhea in HIV/AIDS are associated with B12 deficiency.
Fish tapeworm. Fish tapeworm competes for available B12.
Congenital transcobalamin deficiency. Transcobalamin I and II are glycoproteins which function to bring B12 into cells.
Dietary deficiency. See Nutritional Considerations below.
Folate deficiency may result from:
Alcohol abuse. Alcohol interferes with the enterohepatic cycle and absorption of folate.
Malabsorption. Malabsorptive diseases, such as inflammatory bowel disease and celiac disease, decrease folate absorption.
Pregnancy and breastfeeding. Because fetal and infant growth requires increased folate, pregnancy and breastfeeding may deplete a woman’s folate stores. In turn, an exclusively breastfed infant whose mother is folate-deficient will not receive adequate folate.
Medications. Intake of certain medications, such as methotrexate, phenytoin, and trimethoprim, may lead to folate deficiency.
Hemolysis and exfoliative dermatitis. Both conditions increase the demand for folate.
Vitamin B12 deficiency. Because vitamin B12 is responsible for the formation of the metabolically active form of folic acid, its deficiency can lead to folate deficiency.
Dietary deficiency. See Nutritional Considerations below.
The complete hematologic picture includes:
- Large bone marrow precursor cells of neutrophils and erythrocytes (macro-ovalocytes) with an elevated mean corpuscular volume (MCV). Note: An elevated MCV may not be present if iron deficiency is concurrent. However, a normal MCV does not rule out B12 or folate deficiency.
- Hypersegmented neutrophil nuclei (6 lobes or greater or several 5-lobed cells).
- A complete blood count (CBC) showing anemia. Severe anemia is possible with occasional hemoglobin values < 5.0 g/dL. Absence of depressed hemoglobin or hematocrit levels does not rule out B12 or folate deficiency.
- Normal or depressed reticulocyte counts.
- Marked lactate dehydrogenase (LDH) elevation (in the thousands) due to both ineffective red blood cell production and increased peripheral breakdown.
- Thrombocytopenia and neutropenia.
Bone marrow biopsy is usually not necessary for diagnosis, but typically shows megaloblastosis and hypercellularity with erythroid and myeloid hyperplasia.
Additional tests must be conducted to distinguish between folate and vitamin B12 deficiencies because the hematologic indices revealed by blood smear review and bone marrow aspirate are similar for both deficiency types.
Serum B12 and folate and/or red blood cell folate concentration should be measured. Serum folate can be acutely elevated after a folate-rich meal, whereas red blood cell folate more accurately measures actual stores.
If the serum B12 and folate results are not diagnostic, additional testing can be performed. Note that serum f olate and vitamin B12 assays may be rendered unreliable by pregnancy, alcohol intake, acute nutrition change, or medication use. In these instances, additional tests may aid diagnosis.
Serum methylmalonic acid is elevated in vitamin B12 deficiency and is usually normal in folate deficiency.
Deficiency of vitamin B12 or folate will elevate homocysteine.
Once B12 deficiency is confirmed, a cause should be sought. If there is not an obvious reason for the deficiency (B12-deficient diet without supplementation, history of gastric surgery, etc.) then consider testing for pernicious anemia with anti-parietal cell antibodies or anti-IF antibodies. Because hypothyroidism can be associated with macrocytic anemia and is also associated with pernicious anemia, screening with a thyroid-stimulating hormone (TSH) level should be considered in patients with B12 deficiency.
Identification of the underlying cause of vitamin B12 or folate deficiency is necessary to ensure adequate long-term treatment.
In patients who are symptomatic or have significant hematologic abnormalities, vitamin B12 injections (1000 µ g) are usually given daily for 1 week, then weekly for 4 weeks, and then monthly until hematologic indices have stabilized. Patients with continued risk of deficiency should remain on maintenance therapy which consists of monthly injections or, in highly compliant patients, high dose oral B12 (1000-2000 µ g/day). At high intakes, the vitamin enters the body through diffusion. Vitamin B12 sublingual preparations and a nasal gel are also available for maintenance therapy when compliance is ensured, but there is less information on long-term effectiveness of these treatment routes.
In patients with asymptomatic B12 deficiency, treatment with high-dose daily oral supplementation or monthly injections for at least 8 weeks is usually adequate to reverse hematologic indices. Serum B12 or MMA levels should be monitored and normalized before stopping treatment. Patients at continued risk of deficiency should remain on maintenance therapy for as long as risk factors are present.
Oral folate (1 mg) taken daily for several months usually corrects the deficiency.
Doses up to 5 mg may be used if indicated.
Concomitant B12 deficiency must be ruled out, as folate supplementation can mask the hematologic signs of B12 deficiency, leading to irreversible neurologic injury if not treated. This masking is particularly likely to occur in patients routinely prescribed folate for other medical reasons (e.g., sickle cell anemia).
In individuals following omnivorous diets, dietary vitamin B12 is usually adequate. However, some people, particularly elderly persons, have poorer B12 absorption due to atrophic gastritis or hypochlorhydria, and prevalence of these conditions appears to increase with age. The Food and Nutrition Board advises everyone older than 50 to meet their RDA with B12 fortified foods or a supplement.
The use of histamine H2 receptor blockers or proton pump inhibitors may also interfere with the breakdown of vitamin B12 from food and interfere with B12 absorption. In these situations, low-dose crystalline B12 supplements may prevent B12 deficiency. In cases of intrinsic factor deficiency, intramuscular injections or high-dose supplements (1 mg/day) will prevent or treat pernicious anemia.
Persons who have had gastric bypass surgery are at risk for B12 deficiency. , Individuals who have followed vegan diets for many years without taking B12 supplements and their exclusively breastfed infants are also at risk. In these groups, the risk for vitamin B12 deficiency is easily eliminated with supplementation.
Individuals who abuse alcohol and those with celiac disease are also at higher risk for deficiency. , Individuals infected with H. pylori may also be at risk. A concurrent inhibition of vitamin B12 and folate absorption caused by this organism may result in pernicious anemia.
Due to fortification of grain products with folic acid, anemia resulting from folate deficiency is becoming less frequent. However, alcoholism often leads to poor folate intake and, combined with alcohol’s anti-folate effect, may lead to deficiency.
An autosomal-recessive inborn error of metabolism causes thiamine-responsive megaloblastic anemia (also known as Rogers syndrome). Pharmacologic doses of thiamine (25-200 mg/day) correct the hematologic abnormalities associated with this condition.
Caution is necessary in prescribing folate supplements. As noted above, folic acid can mask signs of vitamin B12 deficiency.
Restrict alcohol use. When appropriate, a psychiatric referral, along with substance abuse counseling and Alcoholics Anonymous meetings or other community-based support, may be helpful.
Vitamin B12 supplementation, intramuscular or oral as indicated.
Oral folate supplementation (rule out B12 deficiency prior to treatment).
What to Tell the Family
Megaloblastic anemia can be easily treated. Appropriate supplementation, increased consumption of folate-rich foods, and reduction of alcohol use can help prevent recurrence. For people following vegan diets, oral vitamin B12 supplementation is necessary. If the primary cause of deficiency is alcohol use, the patient will likely need multilevel support facilitated through the primary care provider.
- Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
- Balt CA: An investigation of the relationship between vitamin B12 deficiency and HIV infection. J Assoc Nurses AIDS Care 11:24, 2000 Jan-Feb [PMID:10670004]
- Carmel R: Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin Chem 49:1367, 2003 [PMID:12881454]
- Dhar M, Bellevue R, Carmel R: Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med 348:2204, 2003 [PMID:12773647]
- Allen LH: How common is vitamin B-12 deficiency? Am J Clin Nutr 89:693S, 2009 [PMID:19116323]
- Baik HW, Russell RM: Vitamin B12 deficiency in the elderly. Annu Rev Nutr 19:357, 1999 [PMID:10448529]
- Jans G et al: Maternal micronutrient deficiencies and related adverse neonatal outcomes after bariatric surgery: a systematic review. Adv Nutr 6:420, 2015 [PMID:26178026]
- Aarts EO, van Wageningen B, Janssen IM, Berends F J. Prevalence of anemia and related deficiencies in the first year following laparoscopic gastric bypass for morbid obesity. J Obes . 2012;2012 .
- Pawlak R et al: How prevalent is vitamin B(12) deficiency among vegetarians? Nutr Rev 71:110, 2013 [PMID:23356638]
- Langan RC, Zawistoski KJ: Update on vitamin B12 deficiency. Am Fam Physician 83:1425, 2011 [PMID:21671542]
- Dahele A, Ghosh S: Vitamin B12 deficiency in untreated celiac disease. Am J Gastroenterol 96:745, 2001 [PMID:11280545]
- Quigley EM, Carmichael HA, Watkinson G: Adult celiac disease (celiac sprue), pernicious anemia and IgA deficiency. Case report and review of the relationships between vitamin B12 deficiency, small intestinal mucosal disease and immunoglobulin deficiency. J Clin Gastroenterol 8:277, 1986 [PMID:3734360]
- Salgueiro J et al: Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther 20:1029, 2004 [PMID:15569104]
- Lindenbaum J, Roman MJ: Nutritional anemia in alcoholism. Am J Clin Nutr 33:2727, 1980 [PMID:7001890]
- Singleton CK, Martin PR: Molecular mechanisms of thiamine utilization. Curr Mol Med 1:197, 2001 [PMID:11899071]
- Bappal B et al: Five years followup of diabetes mellitus in two siblings with thiamine responsive megaloblastic anemia. Indian Pediatr 38:1295, 2001 [PMID:11721072]